These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
| For the quarterly period ended March 31, 2011 |
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
| For the transition period from __________________to __________________ |
|
Delaware
|
62-1612879
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
100 North Point Center East, Suite 600
|
|
|
Alpharetta, Georgia
|
30022
|
|
(Address of principal executive offices)
|
(Zip code)
|
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
|
|
(Do not check if a smaller reporting company)
|
||||
|
Page
|
|||
|
Part I
|
FINANCIAL INFORMATION
|
||
|
1
|
|||
| 16 | |||
| 25 | |||
| 25 | |||
|
Part II
|
OTHER INFORMATION
|
||
| 26 | |||
| 26 | |||
| 26 | |||
| 26 | |||
| 26 | |||
| 26 | |||
| 27 | |||
| 28 | |||
|
Three Months Ended
|
||||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||
|
Net Sales
|
$
|
180.7
|
$
|
192.8
|
||||
|
Cost of products sold
|
133.5
|
139.3
|
||||||
|
Gross Profit
|
47.2
|
53.5
|
||||||
|
Selling expense
|
5.1
|
5.2
|
||||||
|
Research expense
|
2.0
|
2.0
|
||||||
|
General expense
|
12.7
|
11.7
|
||||||
|
Total nonmanufacturing expenses
|
19.8
|
18.9
|
||||||
|
Restructuring and impairment expense
|
1.0
|
3.6
|
||||||
|
Operating Profit
|
26.4
|
31.0
|
||||||
|
Interest expense
|
—
|
0.4
|
||||||
|
Other income (expense), net
|
0.2
|
(1.1
|
)
|
|||||
|
Income from Continuing Operations before Income Taxes and Income from Equity Affiliates
|
26.6
|
29.5
|
||||||
|
Provision for income taxes
|
10.9
|
10.3
|
||||||
|
Income from equity affiliates
|
0.9
|
0.6
|
||||||
|
Income from Continuing Operations
|
16.6
|
19.8
|
||||||
|
Loss from Discontinued Operations
|
(0.4
|
)
|
(1.2
|
)
|
||||
|
Net Income
|
$
|
16.2
|
$
|
18.6
|
||||
|
Net Income per Share - Basic:
|
||||||||
|
Income per share from continuing operations
|
$
|
0.93
|
$
|
1.11
|
||||
|
Loss per share from discontinued operations
|
(0.02
|
)
|
(0.07
|
)
|
||||
|
Net income per share – basic
|
$
|
0.91
|
$
|
1.04
|
||||
|
Net Income per Share – Diluted:
|
||||||||
|
Income per share from continuing operations
|
$
|
0.93
|
$
|
1.09
|
||||
|
Loss per share from discontinued operations
|
(0.2
|
)
|
(0.07
|
)
|
||||
|
Net income per share – diluted
|
$
|
0.91
|
$
|
1.02
|
||||
|
Cash Dividends Declared Per Share
|
$
|
0.15
|
$
|
0.15
|
||||
|
Weighted Average Shares Outstanding:
|
||||||||
|
Basic
|
17,432,800
|
17,807,800
|
||||||
|
Diluted
|
17,537,200
|
18,164,400
|
||||||
|
March 31,
2011
|
December 31,
2010
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
77.2
|
$
|
87.3
|
||||
|
Accounts receivable
|
101.6
|
98.9
|
||||||
|
Inventories
|
124.2
|
113.8
|
||||||
|
Income taxes receivable
|
9.3
|
0.9
|
||||||
|
Other current assets
|
12.9
|
11.9
|
||||||
|
Total Current Assets
|
325.2
|
312.8
|
||||||
|
Property, Plant and Equipment, net
|
464.7
|
440.8
|
||||||
|
Deferred Income Tax Benefits
|
6.8
|
11.8
|
||||||
|
Investment in Equity Affiliates
|
21.5
|
20.5
|
||||||
|
Goodwill and Intangible Assets
|
8.9
|
8.8
|
||||||
|
Other Assets
|
56.4
|
55.7
|
||||||
|
Total Assets
|
$
|
883.5
|
$
|
850.4
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Current debt
|
$
|
9.2
|
$
|
8.7
|
||||
|
Accounts payable
|
59.0
|
66.4
|
||||||
|
Accrued expenses
|
94.1
|
105.6
|
||||||
|
Current deferred revenue
|
3.6
|
6.0
|
||||||
|
Total Current Liabilities
|
165.9
|
186.7
|
||||||
|
Long-Term Debt
|
101.5
|
43.1
|
||||||
|
Pension and Other Postretirement Benefits
|
47.6
|
46.3
|
||||||
|
Deferred Income Tax Liabilities
|
30.1
|
28.9
|
||||||
|
Other Liabilities
|
20.8
|
21.2
|
||||||
|
Total Liabilities
|
365.9
|
326.2
|
||||||
|
Stockholders’ Equity:
|
||||||||
|
Preferred stock, $0.10 par value; 10,000,000 shares authorized; none issued or outstanding
|
—
|
—
|
||||||
|
Common stock, $0.10 par value; 100,000,000 shares authorized; 18,722,450 and 18,721,474 shares issued at March 31, 2011 and December 31, 2010, respectively; 17,540,852 and 18,027,903 shares outstanding at March 31, 2011 and December 31, 2010, respectively
|
1.9
|
1.9
|
||||||
|
Additional paid-in-capital
|
205.8
|
208.8
|
||||||
|
Common stock in treasury, at cost, 1,181,598 and 693,571 shares at March 31, 2011 and December 31, 2010, respectively
|
(57.3
|
)
|
(24.4
|
)
|
||||
|
Retained earnings
|
349.9
|
336.4
|
||||||
|
Accumulated other comprehensive income, net of tax
|
17.3
|
1.5
|
||||||
|
Total Stockholders’ Equity
|
517.6
|
524.2
|
||||||
|
Total Liabilities and Stockholders’ Equity
|
$
|
883.5
|
$
|
850.4
|
||||
|
Common Stock Issued
|
Treasury Stock
|
|||||||||||||||||||||||||||||||
|
Shares
|
Amount
|
Additional
Paid-In
Capital
|
Shares
|
Amount
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Total
|
|||||||||||||||||||||||||
|
Balance, December 31, 2009
|
18,633,235
|
$
|
1.9
|
$
|
205.7
|
758,350
|
$
|
(14.0
|
)
|
$
|
281.9
|
$
|
6.7
|
$
|
482.2
|
|||||||||||||||||
|
Net income for the three months ended March 31, 2010
|
18.6
|
18.6
|
||||||||||||||||||||||||||||||
|
Adjustments to unrealized foreign currency translation,
|
(10.4
|
)
|
(10.4
|
)
|
||||||||||||||||||||||||||||
|
Changes in fair value of derivative instruments, net of tax
|
(2.2
|
)
|
(2.2
|
)
|
||||||||||||||||||||||||||||
|
Amortization of postretirement benefit plans’ costs, net of tax
|
0.6
|
0.6
|
||||||||||||||||||||||||||||||
|
Comprehensive income, net of tax
|
6.6
|
|||||||||||||||||||||||||||||||
|
Dividends declared ($0.15 per share)
|
(2.7
|
)
|
(2.7
|
)
|
||||||||||||||||||||||||||||
|
Restricted stock issuances, net
|
(8.6
|
)
|
(450,473
|
)
|
8.6
|
—
|
||||||||||||||||||||||||||
|
Stock-based employee compensation expense
|
2.1
|
2.1
|
||||||||||||||||||||||||||||||
|
Excess tax benefits of stock-based employee compensation
|
1.0
|
1.0
|
||||||||||||||||||||||||||||||
|
Stock issued to directors as compensation
|
639
|
—
|
0.1
|
—
|
0.1
|
|||||||||||||||||||||||||||
|
Issuance of shares for options exercised
|
44,701
|
—
|
1.1
|
1.1
|
||||||||||||||||||||||||||||
|
Purchases of treasury stock
|
—
|
—
|
—
|
8,491
|
(0.6
|
)
|
—
|
—
|
(0.6
|
)
|
||||||||||||||||||||||
|
Balance, March 31, 2010
|
18,678,575
|
$
|
1.9
|
$
|
201.4
|
316,368
|
$
|
(6.0
|
)
|
$
|
297.8
|
$
|
(5.3
|
)
|
$
|
489.8
|
||||||||||||||||
|
Balance, December 31, 2010
|
18,721,474
|
$
|
1.9
|
$
|
208.8
|
693,571
|
$
|
(24.4
|
)
|
$
|
336.4
|
$
|
1.5
|
$
|
524.2
|
|||||||||||||||||
|
Net income for the three months ended March 31, 2011
|
16.2
|
16.2
|
||||||||||||||||||||||||||||||
|
Adjustments to unrealized foreign currency translation,
|
13.4
|
13.4
|
||||||||||||||||||||||||||||||
|
Changes in fair value of derivative instruments, net of tax
|
1.5
|
1.5
|
||||||||||||||||||||||||||||||
|
Amortization of postretirement benefit plans’ costs, net of tax
|
0.9
|
0.9
|
||||||||||||||||||||||||||||||
|
Comprehensive income, net of tax
|
32.0
|
|||||||||||||||||||||||||||||||
|
Dividends declared ($0.15 per share)
|
(2.7
|
)
|
(2.7
|
)
|
||||||||||||||||||||||||||||
|
Restricted stock issuances, net
|
(12.9
|
)
|
(315,310
|
)
|
12.9
|
—
|
||||||||||||||||||||||||||
|
Stock-based employee compensation expense
|
0.9
|
0.9
|
||||||||||||||||||||||||||||||
|
Excess tax benefits of stock-based employee compensation
|
9.0
|
9.0
|
||||||||||||||||||||||||||||||
|
Stock issued to directors as compensation
|
476
|
—
|
—
|
—
|
||||||||||||||||||||||||||||
|
Issuance of shares for options exercised
|
500
|
—
|
— |
—
|
||||||||||||||||||||||||||||
|
Purchases of treasury stock
|
—
|
—
|
—
|
803,337
|
(45.8
|
)
|
—
|
—
|
(45.8
|
)
|
||||||||||||||||||||||
|
Balance, March 31, 2011
|
18,722,450
|
$
|
1.9
|
$
|
205.8
|
1,181,598
|
$
|
(57.3
|
)
|
$
|
349.9
|
$
|
17.3
|
$
|
517.6
|
|||||||||||||||||
|
Three Months Ended
|
||||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||
|
Operations
|
||||||||
|
Net income
|
$
|
16.2
|
$
|
18.6
|
||||
|
Less: Loss from discontinued operations
|
0.4
|
1.2
|
||||||
|
Income from continuing operations
|
16.6
|
19.8
|
||||||
|
Non-cash items included in net income:
|
||||||||
|
Depreciation and amortization
|
10.7
|
10.0
|
||||||
|
Amortization of deferred revenue
|
(2.4
|
)
|
(1.8
|
)
|
||||
|
Deferred income tax provision
|
3.9
|
7.0
|
||||||
|
Pension and other postretirement benefits
|
1.4
|
0.7
|
||||||
|
Stock-based compensation
|
0.9
|
2.1
|
||||||
|
Income from equity affiliate
|
(0.9
|
)
|
(0.6
|
)
|
||||
|
Other items
|
(1.6
|
)
|
(3.6
|
)
|
||||
|
Net changes in operating working capital
|
(26.5
|
)
|
5.2
|
|||||
|
Net cash provided (used) by operating activities of:
|
||||||||
|
- Continuing operations
|
2.1
|
38.8
|
||||||
|
- Discontinued operations
|
(2.3
|
)
|
(7.4
|
)
|
||||
|
Cash Provided (Used) by Operations
|
(0.2
|
)
|
31.4
|
|||||
|
Investing
|
||||||||
|
Capital spending
|
(27.7
|
)
|
(9.9
|
)
|
||||
|
Capitalized software costs
|
(0.8
|
)
|
(2.7
|
)
|
||||
|
Other
|
2.0
|
3.1
|
||||||
|
Cash Used for Investing
|
(26.5
|
)
|
(9.5
|
)
|
||||
|
Financing
|
||||||||
|
Cash dividends paid to SWM stockholders
|
(2.7
|
)
|
(2.7
|
)
|
||||
|
Changes in short-term debt
|
0.2
|
0.5
|
||||||
|
Proceeds from issuances of long-term debt
|
56.1
|
43.7
|
||||||
|
Payments on long-term debt
|
(0.2
|
)
|
(52.5
|
)
|
||||
|
Purchases of treasury stock
|
(45.8
|
)
|
(0.6
|
)
|
||||
|
Proceeds from exercise of stock options
|
—
|
1.1
|
||||||
|
Excess tax benefits of stock-based awards
|
9.0
|
1.0
|
||||||
|
Cash Provided by (Used in) Financing
|
16.6
|
(9.5
|
)
|
|||||
|
Effect of Exchange Rate Changes on Cash
|
—
|
0.6
|
||||||
|
Increase (Decrease) in Cash and Cash Equivalents
|
(10.1
|
)
|
13.0
|
|||||
|
Cash and Cash Equivalents at beginning of period
|
87.3
|
56.9
|
||||||
|
Cash and Cash Equivalents at end of period
|
$
|
77.2
|
$
|
69.9
|
||||
|
March 31, 2011
|
December 31,
2010
|
|||||||
|
Assets of discontinued operations:
|
||||||||
|
Current assets
|
$
|
3.7
|
$
|
3.9
|
||||
|
Noncurrent deferred income tax benefits
|
8.7
|
8.0
|
||||||
|
Other assets – assets held for sale
|
0.3
|
0.4
|
||||||
|
Liabilities of discontinued operations:
|
||||||||
|
Current liabilities
|
11.1
|
12.2
|
||||||
|
Three Months Ended
March 31
|
||||||||
|
2011
|
2010
|
|||||||
|
Net sales
|
$
|
—
|
$
|
0.2
|
||||
|
Restructuring and impairment expense
|
0.3
|
1.2
|
||||||
|
Loss from discontinued operations before income taxes
|
(0.6
|
)
|
(1.8
|
)
|
||||
|
Income tax benefit
|
0.2
|
0.6
|
||||||
|
Loss from discontinued operations
|
$
|
(0.4
|
)
|
$
|
(1.2
|
)
|
||
|
Three Months
Ended
|
Year Ended
|
|||||||
|
March 31,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
Balance at beginning of year
|
$
|
9.2
|
$
|
20.9
|
||||
|
Accruals for announced programs
|
0.3
|
7.7
|
||||||
|
Cash payments
|
(1.8
|
)
|
(17.8
|
)
|
||||
|
Exchange rate impacts
|
0.5
|
(1.6
|
)
|
|||||
|
Balance at end of period
|
$
|
8.2
|
$
|
9.2
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||
|
Numerator (basic and diluted):
|
||||||||
|
Net income
|
$
|
16.2
|
$
|
18.6
|
||||
|
Less: Dividends paid to participating securities
|
—
|
—
|
||||||
|
Less: Undistributed earnings available to participating securities
|
0.3
|
0.1
|
||||||
|
Undistributed and distributed earnings available to common shareholders
|
$
|
15.9
|
$
|
18.5
|
||||
|
Denominator:
|
||||||||
|
Average number of common shares outstanding
|
17,432.8
|
17,807.8
|
||||||
|
Effect of dilutive stock-based compensation
|
104.4
|
356.6
|
||||||
|
Average number of common and potential common shares outstanding
|
17,537.2
|
18,164.4
|
||||||
|
March 31,
2011
|
December 31,
2010
|
|||||||
|
Raw materials
|
$
|
32.7
|
$
|
31.7
|
||||
|
Work in process
|
27.0
|
23.8
|
||||||
|
Finished goods
|
43.9
|
37.1
|
||||||
|
Supplies and other
|
20.6
|
21.2
|
||||||
|
Total
|
$
|
124.2
|
$
|
113.8
|
||||
|
Reconstituted Tobacco
|
Paper
|
Total
|
||||||||||
|
Goodwill
|
$
|
5.8
|
$
|
2.7
|
$
|
8.5
|
||||||
|
Accumulated impairment losses
|
—
|
(2.7
|
)
|
(2.7
|
)
|
|||||||
|
Balance as of January 1, 2011
|
5.8
|
—
|
5.8
|
|||||||||
|
Foreign currency translation adjustments
|
0.3
|
—
|
0.3
|
|||||||||
|
Goodwill
|
$
|
6.1
|
$
|
2.7
|
$
|
8.8
|
||||||
|
Accumulated impairment losses
|
—
|
(2.7
|
)
|
(2.7
|
)
|
|||||||
|
Balance as of March 31, 2011
|
$
|
6.1
|
$
|
—
|
$
|
6.1
|
||||||
|
March 31, 2011
|
December 31, 2010
|
|||||||||||||||||||||||
|
Gross
Carrying
Amount
|
Accumulated
Amortization*
|
Net
Carrying
Amount
|
Gross
Carrying
Amount
|
Accumulated
Amortization*
|
Net
Carrying
Amount
|
|||||||||||||||||||
|
Customer-related intangibles (Reconstituted Tobacco Segment)
|
$
|
10.0
|
$
|
7.2
|
$
|
2.8
|
$
|
10.0
|
$
|
7.0
|
$
|
3.0
|
||||||||||||
|
Three Months
Ended
|
Year Ended
|
|||||||
|
March 31,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
Balance at beginning of year
|
$
|
10.0
|
$
|
12.1
|
||||
|
Accruals for announced programs
|
1.0
|
10.2
|
||||||
|
Cash payments
|
(4.6
|
)
|
(11.2
|
)
|
||||
|
Exchange rate impacts
|
0.4
|
(1.1
|
)
|
|||||
|
Balance at end of period
|
$
|
6.8
|
$
|
10.0
|
||||
|
March 31,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
Credit Agreement
|
||||||||
|
U. S. Revolver
|
$
|
56.0
|
$
|
—
|
||||
|
Euro Revolver
|
35.4
|
33.5
|
||||||
|
French Employee Profit Sharing
|
11.7
|
11.2
|
||||||
|
Bank Overdrafts
|
5.8
|
6.6
|
||||||
|
Other
|
1.8
|
0.5
|
||||||
|
Total Debt
|
110.7
|
51.8
|
||||||
|
Less: Current debt
|
(9.2
|
)
|
(8.7
|
)
|
||||
|
Long-Term Debt
|
$
|
101.5
|
$
|
43.1
|
||||
|
Asset Derivatives
|
Liability Derivatives
|
||||||||||||
|
Balance Sheet
Location
|
Fair
Value
|
Balance Sheet
Location
|
Fair
Value
|
||||||||||
|
Derivatives designated as hedges:
|
|||||||||||||
|
Foreign exchange contracts
|
Accounts Receivable
|
$
|
3.9
|
Accounts Payable
|
$
|
—
|
|||||||
|
Foreign exchange contracts
|
Property, Plant & Equipment
|
(0.4
|
)
|
Other Liabilities
|
—
|
||||||||
|
Foreign exchange contracts
|
Other Assets
|
4.3
|
|||||||||||
|
Total derivatives designated as hedges
|
7.8
|
—
|
|||||||||||
|
Derivatives not designated as hedges:
|
|||||||||||||
|
Interest rate contracts
|
Other Assets
|
—
|
Other Liabilities
|
0.6
|
|||||||||
|
Foreign exchange contracts
|
Accounts Receivable
|
Accounts Payable
|
0.1
|
||||||||||
|
Total derivatives not designated as hedges
|
—
|
||||||||||||
|
Total derivatives
|
$
|
7.8
|
$
|
0.7
|
|||||||||
|
Asset Derivatives
|
Liability Derivatives
|
||||||||||||
|
Balance Sheet
Location
|
Fair
Value
|
Balance Sheet
Location
|
Fair
Value
|
||||||||||
|
Derivatives designated as hedges:
|
|||||||||||||
|
Foreign exchange contracts
|
Accounts Receivable
|
$
|
4.2
|
Accounts Payable
|
$
|
—
|
|||||||
|
Foreign exchange contracts
|
Property, Plant & Equipment
|
(0.3
|
)
|
Other Liabilities
|
—
|
||||||||
|
Foreign exchange contracts
|
Other Assets
|
3.6
|
|||||||||||
|
Total derivatives designated as hedges
|
7.5
|
—
|
|||||||||||
|
Derivatives not designated as hedges:
|
|||||||||||||
|
Interest rate contracts
|
Other Assets
|
—
|
Other Liabilities
|
0.7
|
|||||||||
|
Foreign exchange contracts
|
Accounts Receivable
|
—
|
Accounts Payable
|
0.4
|
|||||||||
|
Total derivatives not designated as hedges
|
—
|
1.1
|
|||||||||||
|
Total derivatives
|
$
|
7.5
|
$
|
1.1
|
|||||||||
|
The Effect of Cash Flow Hedge Derivative Instruments on the Consolidated Statement of Income
for the Three Months Ended March 31, 2011
|
||||||||||||||||||||
|
Change in
AOCI
Gain /
(Loss)
|
Location of Gain
/(Loss)
reclassified from
AOCI into
Income
(Effective
Portion)
|
Gain /(Loss)
Reclassified
from AOCI
into Income
(Effective
Portion)
|
Location of Gain /
(Loss) Recognized in
Income (Ineffective
Portion and Amount
Excluded from
Effectiveness Testing)
|
Gain / (Loss)
Recognized in
Income (Ineffective
Portion and
Amount excluded
from Effectiveness
Testing)
|
||||||||||||||||
|
Derivatives designated as hedges:
|
||||||||||||||||||||
|
Three Months Ended:
|
||||||||||||||||||||
|
Foreign exchange contracts
|
$ | 1.5 | Net Sales | $ | 1.4 | Other Income/ (Expense) | $ | — | ||||||||||||
|
The Effect of Cash Flow Hedge Derivative Instruments on the Consolidated Statement of Income
for the Three Months Ended March 31, 2010
|
||||||||||||||||||||
|
Change in
AOCI
Gain
/ (Loss)
|
Location of Gain
/(Loss)
reclassified from
AOCI into
Income
(Effective
Portion)
|
Gain /(Loss)
Reclassified
from AOCI
into Income
(Effective
Portion)
|
Location of Gain /
(Loss) Recognized in
Income (Ineffective
Portion and Amount
Excluded from
Effectiveness Testing)
|
Gain / (Loss)
Recognized in
Income (Ineffective
Portion and
Amount excluded
from Effectiveness
Testing)
|
||||||||||||||||
|
Derivatives designated as hedges:
|
||||||||||||||||||||
|
Three Months Ended
|
||||||||||||||||||||
|
Foreign exchange contracts
|
$ | (2.2 | ) | Net Sales | $ | 1.7 | Other Income/ (Expense) | $ | — | |||||||||||
|
Derivatives not designated as
hedging instruments
|
Location of Gain / (Loss)
Recognized in Income on
Derivatives
|
Amount of Gain / (Loss) Recognized in
Income on Derivatives for the Three
Months Ended
|
||||||||||
|
March 31, 2011
|
March 31, 2010
|
|||||||||||
|
Interest rate contracts
|
Other Income / Expense
|
$
|
0.1
|
$
|
(0.3
|
)
|
||||||
|
Foreign exchange contracts
|
Other Income / Expense
|
(1.2.
|
)
|
—
|
||||||||
|
Total
|
$
|
(1.1
|
)
|
$
|
(0.3
|
)
|
||||||
|
Three Months Ended March 31
|
||||||||||||||||||||||||
|
U.S. Pension Benefits
|
French Pension Benefits
|
U.S. OPEB Benefits
|
||||||||||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||||||||
|
Service cost
|
$
|
—
|
$
|
—
|
$
|
0.2
|
$
|
0.2
|
$
|
—
|
$
|
—
|
||||||||||||
|
Interest cost
|
1.5
|
1.6
|
0.4
|
0.3
|
0.2
|
0.2
|
||||||||||||||||||
|
Expected return on plan assets
|
(1.9
|
)
|
(2.2
|
)
|
(0.1
|
)
|
(0.2
|
)
|
—
|
—
|
||||||||||||||
|
Amortizations and other
|
1.1
|
0.8
|
0.2
|
0.1
|
—
|
—
|
||||||||||||||||||
|
Net periodic benefit cost
|
$
|
0.7
|
$
|
0.2
|
$
|
0.7
|
$
|
0.4
|
$
|
0.2
|
$
|
0.2
|
||||||||||||
|
Three Months Ended
|
||||||||||||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||||||||||
|
Tax provision at U.S. statutory rate
|
$
|
9.3
|
35.0
|
%
|
$
|
10.3
|
35.0
|
%
|
||||||||
|
Tax benefits of foreign legal structure
|
(0.6
|
)
|
(2.3
|
)
|
(0.5
|
)
|
(1.7
|
)
|
||||||||
|
Other foreign taxes, net
|
2.1
|
7.9
|
0.6
|
2.0
|
||||||||||||
|
Other, net.
|
0.1
|
0.4
|
(0.1
|
)
|
(0.3
|
)
|
||||||||||
|
Provision for income taxes
|
$
|
10.9
|
41.0
|
%
|
$
|
10.3
|
35.0
|
%
|
||||||||
|
Three Months Ended
|
||||||||||||||||
|
March 31, 2011
|
March 31, 2010
|
|||||||||||||||
|
Paper
|
$
|
125.1
|
69.2
|
%
|
$
|
131.1
|
68.0
|
%
|
||||||||
|
Reconstituted Tobacco
|
55.6
|
30.8
|
61.7
|
32.0
|
||||||||||||
|
Total Consolidated
|
$
|
180.7
|
100.0
|
%
|
$
|
192.8
|
100.0
|
%
|
||||||||
|
Three Months Ended
|
||||||||||||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||||||||||
|
Paper
|
$
|
10.2
|
38.6
|
%
|
$
|
9.2
|
29.7
|
%
|
||||||||
|
Reconstituted Tobacco
|
20.0
|
75.8
|
25.9
|
83.5
|
||||||||||||
|
Unallocated
|
(3.8
|
)
|
(14.4
|
)
|
(4.1
|
)
|
(13.2
|
)
|
||||||||
|
Total Consolidated
|
$
|
26.4
|
100.0
|
%
|
$
|
31.0
|
100.0
|
%
|
||||||||
|
Three Months Ended
|
||||||||||||||||
|
March 31, 2011
|
March 31, 2010
|
|||||||||||||||
|
Net sales
|
$
|
180.7
|
100.0
|
%
|
$
|
192.8
|
100.0
|
%
|
||||||||
|
Gross profit
|
47.2
|
26.1
|
53.5
|
27.7
|
||||||||||||
|
Restructuring & impairment expense
|
1.0
|
0.5
|
3.6
|
1.9
|
||||||||||||
|
Operating profit
|
26.4
|
14.6
|
31.0
|
16.1
|
||||||||||||
|
Interest expense
|
—
|
—
|
0.4
|
0.2
|
||||||||||||
|
Income from continuing operations
|
16.6
|
9.2
|
19.8
|
10.2
|
||||||||||||
|
Loss from discontinued operations
|
(0.4
|
)
|
(0.2
|
)
|
(1.2
|
)
|
(0.6
|
)
|
||||||||
|
Net income
|
16.2
|
9.0
|
%
|
18.6
|
9.6
|
%
|
||||||||||
|
Diluted earnings per share from continuing operations
|
$
|
0.93
|
$
|
1.09
|
||||||||||||
|
Diluted earnings per share
|
$
|
0.91
|
$
|
1.02
|
||||||||||||
|
Cash provided by (used in) operations
|
$
|
(0.2
|
)
|
$
|
31.4
|
|||||||||||
|
Capital spending
|
$
|
27.7
|
$
|
9.9
|
||||||||||||
|
|
Three Months Ended
|
Consolidated
Sales
|
||||||||||||||||||
|
Net Sales
(dollars in millions) |
March 31,
2011
|
March 31,
2010
|
Change
|
Percent
Change
|
Volume
Change
|
|||||||||||||||
|
Paper
|
$
|
125.1
|
$
|
131.1
|
$
|
(6.0
|
)
|
(4.6)
|
%
|
(6.1
|
)%
|
|||||||||
|
Reconstituted Tobacco
|
55.6
|
61.7
|
(6.1
|
)
|
(9.9)
|
(10.0
|
)
|
|||||||||||||
|
Total
|
$
|
180.7
|
$
|
192.8
|
$
|
(12.1
|
)
|
(6.3)
|
%
|
(7.7
|
)%
|
|||||||||
|
Amount
|
Percent
|
|||||||
|
Changes in product mix and selling prices
|
$
|
(4.9
|
)
|
(2.6)
|
%
|
|||
|
Changes due to volume
|
(4.5
|
)
|
(2.3)
|
|||||
|
Changes in currency exchange rates
|
(2.7
|
)
|
(1.4
|
)
|
||||
|
Total
|
$
|
(12.1
|
)
|
(6.3)
|
%
|
|||
|
●
|
A sales mix which included a higher proportion of lower-priced Paper products had an unfavorable impact of $4.9 million, or 2.6%, on net sales.
|
|
●
|
Unit sales volumes decreased by 7.7% in the three month period ended March 31, 2011 versus the prior-year quarter. The decline in overall volumes negatively impacted net sales by $4.5 million.
|
|
o
|
Sales volumes for the Paper segment decreased by 6.1%. Sales volume for traditional paper products declined in certain markets partially offset by an 8.0% increase in LIP paper sales volume. The dollar impact of increased LIP volumes more than offset the dollar impact of decline in traditional paper volume.
|
|
o
|
Sales volumes in the Reconstituted Tobacco segment decreased by 10.0% primarily due to the decreased demand for reconstituted tobacco leaf, or RTL, products.
|
|
●
|
Changes in currency exchange rates had an unfavorable impact on net sales of $2.7 million, or 1.4%, in the three month period ended March 31, 2011 and primarily reflected the impact of changes in the value of the euro compared with the U.S. dollar in the first quarter of 2011 versus the prior-year quarter.
|
|
Three Months Ended
|
||||||||||||||||||||||||
|
March 31,
2011
|
March 31,
2010
|
Change
|
Percent
Change
|
Percent of Net Sales
|
||||||||||||||||||||
|
2011
|
2010
|
|||||||||||||||||||||||
|
Net Sales
|
$
|
180.7
|
$
|
192.8
|
$
|
(12.1
|
)
|
(6.3
|
)%
|
100.0
|
%
|
100.0
|
%
|
|||||||||||
|
Cost of products sold
|
133.5
|
139.3
|
(5.8
|
)
|
(4.2
|
)
|
73.9
|
72.3
|
||||||||||||||||
|
Gross Profit
|
$
|
47.2
|
$
|
53.5
|
$
|
(6.3
|
)
|
(11.8
|
)%
|
26.1
|
%
|
27.7
|
%
|
|||||||||||
|
Three Months Ended
|
||||||||||||||||||||||||
|
March 31,
2011
|
March 31,
2010
|
Change
|
Percent
Change
|
Percent of Net Sales
|
||||||||||||||||||||
|
2011
|
2010
|
|||||||||||||||||||||||
|
Selling expense
|
$
|
5.1
|
$
|
5.2
|
$
|
(0.1
|
)
|
(1.9)
|
%
|
2.8
|
%
|
2.7
|
%
|
|||||||||||
|
Research expense
|
2.0
|
2.0
|
—
|
—
|
1.1
|
1.0
|
||||||||||||||||||
|
General expense
|
12.7
|
11.7
|
1.0
|
8.5
|
7.0
|
6.1
|
||||||||||||||||||
|
Nonmanufacturing expenses
|
$
|
19.8
|
$
|
18.9
|
$
|
0.9
|
4.8
|
%
|
11.0
|
%
|
9.8
|
%
|
||||||||||||
|
Three Months Ended
|
Return on Net
|
|||||||||||||||||||
|
March 31,
|
March 31,
|
Sales
|
||||||||||||||||||
|
2011
|
2010
|
Change
|
2011
|
2010
|
||||||||||||||||
|
Paper
|
$
|
10.2
|
$
|
9.2
|
$
|
1.0
|
8.2
|
%
|
7.0
|
%
|
||||||||||
|
Reconstituted Tobacco
|
20.0
|
25.9
|
(5.9
|
)
|
36.0
|
42.0
|
||||||||||||||
|
Unallocated expenses
|
(3.8
|
)
|
(4.1
|
)
|
0.3
|
|||||||||||||||
|
Total
|
$
|
26.4
|
$
|
31.0
|
$
|
(4.6
|
)
|
14.6
|
%
|
16.1
|
%
|
|||||||||
|
●
|
$3.4 million in lower restructuring expenses
|
|
●
|
$3.1 million sales volume impact of high-value products despite lower volumes
|
|
●
|
$2.7 million in benefits from cost saving and lean manufacturing initiatives
|
|
●
|
These positive factors were mostly offset by $4.9 million in higher inflationary costs, primarily from wood pulp and energy, $1.9 million unfavorable impacts of lower selling prices and product mix and $1.4 million unfavorable foreign currency impacts.
|
|
●
|
$2.3 million from lower sales volumes
|
|
●
|
$1.3 million from higher inflationary costs primarily from energy and labor
|
|
($ in millions)
|
Three Months Ended
|
|||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||
|
Income from continuing operations
|
$
|
16.6
|
$
|
19.8
|
||||
|
Non-cash items included in net income:
|
||||||||
|
Depreciation and amortization
|
10.7
|
10.0
|
||||||
|
Amortization of deferred revenue
|
(2.4
|
)
|
(1.8
|
)
|
||||
|
Deferred income tax provision
|
3.9
|
7.0
|
||||||
|
Pension and other postretirement benefits
|
1.4
|
0.7
|
||||||
|
Stock-based compensation
|
0.9
|
2.1
|
||||||
|
(Income) loss from equity affiliate
|
(0.9
|
)
|
(0.6
|
)
|
||||
|
Other items
|
(1.6
|
)
|
(3.6
|
)
|
||||
|
Net changes in operating working capital
|
(26.5
|
)
|
5.2
|
|||||
|
Net cash provided (used) by operating activities of:
|
||||||||
|
Continuing operations
|
2.1
|
38.8
|
||||||
|
Discontinued operations
|
(2.3
|
)
|
(7.4
|
)
|
||||
|
Cash Provided (Used) by Operations
|
$
|
(0.2
|
)
|
$
|
31.4
|
|||
|
Operating Working Capital
|
||||||||
|
($ in millions)
|
Three Months Ended
|
|||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||
|
Changes in operating working capital
|
||||||||
|
Accounts receivable
|
$
|
2.5
|
$
|
(18.5
|
)
|
|||
|
Inventories
|
(6.6
|
)
|
6.3
|
|||||
|
Prepaid expenses
|
(1.4
|
)
|
2.2
|
|||||
|
Accounts payable
|
(8.3
|
)
|
2.3
|
|||||
|
Accrued expenses
|
(3.9
|
)
|
(4.2
|
)
|
||||
|
Accrued income taxes
|
(8.8
|
)
|
21.5
|
|||||
|
Net changes in operating working capital
|
$
|
(26.5
|
)
|
$
|
5.2
|
|||
|
Cash Flows from Investing Activities
($ in millions)
|
Three Months Ended
|
|||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||
|
Capital spending
|
$
|
(27.7
|
)
|
$
|
(9.9
|
)
|
||
|
Capitalized software costs
|
(0.8
|
)
|
(2.7
|
)
|
||||
|
Other
|
2.0
|
3.1
|
||||||
|
Cash Used for Investing
|
$
|
(26.5
|
)
|
$
|
(9.5
|
)
|
||
|
Cash Flows from Financing Activities
($ in millions)
|
Three Months Ended
|
|||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||
|
Cash dividends paid to SWM stockholders
|
$
|
(2.7
|
)
|
$
|
(2.7
|
)
|
||
|
Net proceeds from (payments on) borrowings
|
56.1
|
(8.3
|
)
|
|||||
|
Purchases of treasury stock
|
(45.8
|
)
|
(0.6
|
)
|
||||
|
Proceeds from exercises of stock options
|
—
|
1.1
|
||||||
|
Excess tax benefits of stock-based awards
|
9.0
|
1.0
|
||||||
|
Cash Provided by (Used in) Financing
|
$
|
16.6
|
$
|
(9.5
|
)
|
|||
|
($ in millions)
|
Three Months Ended
|
|||||||
|
March 31,
2011
|
March 31,
2010
|
|||||||
|
Changes in short-term debt
|
$
|
0.2
|
$
|
0.5
|
||||
|
Proceeds from issuances of long-term debt
|
56.1
|
43.7
|
||||||
|
Payments on long-term debt
|
(0.2
|
)
|
(52.5
|
)
|
||||
|
Net proceeds from (payments on) borrowings
|
$
|
56.1
|
$
|
(8.3
|
)
|
|||
|
●
|
Schweitzer-Mauduit has manufacturing facilities in seven countries, a joint venture in China, and sells products in over 90 countries. As a result, it is subject to a variety of import and export, tax, foreign currency, labor and other regulations within these countries. Changes in these regulations, or adverse interpretations or applications, as well as changes in currency exchange rates, could adversely impact the Company’s business in a variety of ways, including increasing expenses, decreasing sales, limiting its ability to repatriate funds and generally limiting its ability to conduct business. In Brazil, we are currently generating more value-added tax credits than we utilize. As of March, 31, 2011, these credits totaled $16.1 million. We have applied for a special government action to obtain tax exempt status in the state of Rio de Janeiro to enable more rapid utilization of these credits. We expect approval and, if successful, this and other actions should allow our Brazilian operation to utilize more credits than it generates on an annual basis. These credits do not expire; however, if the exemption is not obtained, we may record an allowance for a significant portion of the balance.
|
|
●
|
The Company’s sales are concentrated to a limited number of customers. In 2010, 45% of its sales were to its three largest customers. The loss of one or more of these customers, or a significant reduction in one or more of these customers’ purchases, could have a material adverse effect on the company’s results of operations.
|
|
●
|
The Company’s financial performance is materially impacted by sales of both reconstituted tobacco products and cigarette paper for lower ignition propensity cigarettes. A significant change in sales or production volumes, pricing or manufacturing costs of these products could have a material impact on future financial results. In this regard, Philip Morris – USA began advising the Company in 2009 that it disputes the manner in which the Company has calculated costs for banded cigarette papers under a cost-plus based contract for this product during the period April 2009 through December 2010. Notwithstanding that the dispute is now over a year old, and SWM has consistently advised Philip Morris – USA that it disagrees with its position, Philip Morris -USA to-date has not instituted any formal action to bring this matter to a close. Philip Morris - USA has also consistently paid the full invoiced amount from the date of the first notice of dispute to the present thereby avoiding any contention by SWM that the agreement has been breached for non-payment. Philip Morris - USA’s action reflects a requirement found in the Virginia Uniform Commercial Code, the law that governs the contract, that suggests a party making full payment of a disputed invoice potentially waives any right to recover the amount paid unless such payment is accompanied by an explicit reservation of rights. Currently, the disputed amount is approximately $24.4 million. While the Company believes that it has properly calculated the amount it invoiced, the ultimate resolution of this dispute, if unfavorable to the Company, could have a material adverse effect on the Company’s results of operations.
|
|
●
|
As a result of excess capacity in the tobacco-related papers industry and increased operating costs, competitive levels of selling prices for certain of the Company’s products are not sufficient to cover those costs with a margin that the Company considers reasonable. Such competitive pressures have resulted in downtime of certain paper machines and, in some cases, accelerated depreciation or impairment charges for certain equipment as well as employee severance expenses associated with downsizing activities. The Company will continue to disclose any such actions as they are announced to affected employees or otherwise become certain and will continue to provide updates to any previously disclosed expectations of expenses associated with such actions.
|
|
●
|
The demand for our reconstituted paper product is subject to change depending on the rate at which this product is included in the blend that forms the column of tobacco in various cigarette brands as well as the supply and cost of natural tobacco leaf, which serves to an extent as a substitute for reconstituted tobacco. A change in the inclusion rate or the dynamics of the natural leaf tobacco market can have a material adverse affect on the volume of reconstituted tobacco sales, the price for reconstituted tobacco or both, either of which can have a material adverse effect on our earnings from that product line. In past years, the Company has experienced the adverse effects for one or more years related to changes in the demand and supply relationship for natural leaf.
|
|
●
|
In recent years, governmental entities around the world, particularly in the United States and western Europe, have taken or have proposed actions that may have the effect of reducing consumption of tobacco products. Reports with respect to the possible harmful physical effects of cigarette smoking and use of tobacco products have been publicized for many years and, together with actions to restrict or prohibit advertising and promotion of cigarettes or other tobacco products, to limit smoking in public places and to increase taxes on such products, are intended to discourage the consumption of cigarettes and other such products. Also in recent years, certain governmental entities, particularly in North America, have enacted, considered or proposed actions that would require cigarettes to meet specifications aimed at reducing their likelihood of igniting fires when the cigarettes are not actively being smoked. Furthermore, it is not possible to predict what additional legislation or regulations relating to tobacco products will be enacted, or to what extent, if any, such legislation or regulations might affect our business.
|
|
●
|
Our portfolio of granted patents varies by country, which could have an impact on any competitive advantage provided by patents in individual markets. We rely on patent, trademark, and other intellectual property laws of the United States and other countries to protect our intellectual property rights. In order to maintain the benefits of our patents, we may be required to enforce certain of our patents against infringement through court actions. However, we may be unable to prevent third parties from using our intellectual property or infringing on our patents without our authorization, which may reduce any competitive advantage we have developed. If we have to litigate to protect these rights, any proceedings could be costly, time consuming, could divert management resources, and we may not prevail. We cannot guarantee that any United States or foreign patents, issued or pending, will continue to provide us with any competitive advantage or will not be successfully challenged by third parties. We do not believe that any of our products infringe the valid intellectual property rights of third parties. However, we may be unaware of intellectual property rights of others that may cover some of our products or services. In that event, we may be subject to significant claims for damages. Effectively policing our intellectual property and patents is time consuming and costly, and the steps taken by us may not prevent infringement of our intellectual property, patents or other proprietary rights in our products, technology and trademarks, particularly in foreign countries where in many instances the local laws or legal systems do not offer the same level of protection as in the United States.
|
|
Period
|
Total
Number of
Shares
Purchased
|
Average
Price
Paid per
Share
|
Total Number of Shares
Purchased as Part of
Publicly Announced
Programs
|
Maximum amount of
shares that May Yet
Be Purchased under
the Programs
|
||||||||||||||||
|
(# shares)
|
($ in millions)
|
($ in millions)
|
||||||||||||||||||
|
January 2011
|
2,934
|
$
|
62.49
|
—
|
$
|
—
|
||||||||||||||
|
February 2011
|
800,403
|
$
|
57.07
|
525,000
|
30.0
|
|||||||||||||||
|
March 2011
|
—
|
—
|
—
|
—
|
||||||||||||||||
|
Total Year-to-Date 2011
|
803,337
|
$
|
57.09
|
525,000
|
$
|
30.0
|
$
|
75.0
|
*
|
|||||||||||
|
(a)
|
Exhibits:
|
|
31.1
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
|
101
|
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Income, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Cash Flow, (iv) the Consolidated Statements of Changes in Shareholders’ Equity and Comprehensive Income and (v) Notes to Consolidated Financial Statements tagged as blocks of text. (Furnished herewith.)
|
|
*
|
These Section 906 certifications are not being incorporated by reference into the Form 10-Q filing or otherwise deemed to be filed with the Securities and Exchange Commission.
|
|
By:
|
/s/ PETER J. THOMPSON
|
By:
|
/s/ MARK A. SPEARS
|
|
|
Peter J. Thompson
|
Mark A. Spears
|
|||
|
Executive Vice President, Finance
|
Corporate Controller
|
|||
|
& Strategic Planning
|
(principal accounting officer)
|
|||
|
(duly authorized officer and
|
||||
|
principal financial officer)
|
||||
|
May 4, 2011
|
May 4, 2011
|
|
●
|
“
Banded cigarette paper
” is a type of paper, used to produce lower ignition propensity cigarettes, by applying bands to the paper during the papermaking process.
|
|||
|
●
|
“
Binder
” is used to hold the tobacco leaves in a cylindrical shape during the production process of cigars.
|
|||
|
●
|
“
Cigarette paper
” wraps the column of tobacco within a cigarette and has varying properties such as basis weight, porosity, opacity, tensile strength, texture and burn rate.
|
|||
|
●
|
“
Commercial and industrial products
” include lightweight printing and writing papers, coated papers for packaging and labeling applications, business forms, battery separator paper, drinking straw wrap and other specialized papers.
|
|||
|
●
|
“
Flax
” is a cellulose fiber from a flax plant used as a raw material in the production of certain cigarette papers.
|
|||
|
●
|
“
Lower ignition propensity cigarette paper
” includes banded and print banded cigarette paper, both of which contain bands, which increase the likelihood that an unattended cigarette will self-extinguish.
|
|||
|
●
|
“
Net debt to adjusted EBITDA ratio
” is a financial measurement used in bank covenants where “
Net Debt
“ is defined as the current portion of long term debt plus other short term debt plus long term debt less cash and cash equivalents, and
|
|||
|
●
|
“
Adjusted EBITDA
” is defined as net income excluding extraordinary or 1-time items, net income attributable to noncontrolling interest, interest expense, income taxes and depreciation and amortization less amortization of deferred revenue.
|
|||
|
●
|
“Net debt to capital ratio”
is current and long term debt less cash and cash equivalents, divided by the sum of current debt, long term debt, noncontrolling interest and total stockholders’ equity.
|
|||
|
●
|
“
Net debt to equity ratio
” is current and long term debt less cash and cash equivalents, divided by noncontrolling interest and total stockholders’ equity.
|
|||
|
●
|
“Net operating working capital”
is accounts receivable, inventory, current income tax refunds receivable and prepaid expense, less accounts payable, accrued liabilities and accrued income taxes payable.
|
|||
|
●
|
“Opacity”
is a measure of the extent to which light is allowed to pass through a given material.
|
|||
|
●
|
“Operating profit return on assets”
is operating profit divided by average total assets.
|
|||
|
●
|
“
Plug wrap paper
” wraps the outer layer of a cigarette filter and is used to hold the filter materials in a cylindrical form.
|
|||
|
●
|
“
Print banded cigarette paper
” is a type of paper, used to produce lower ignition propensity cigarettes, with bands added to the paper during a printing process, subsequent to the papermaking process.
|
|||
|
●
|
“
Reconstituted tobacco
” is produced in 2 forms: leaf, or reconstituted tobacco leaf, and wrapper and binder products. Reconstituted tobacco leaf is blended with virgin tobacco as a design aid to achieve certain attributes of finished cigarettes. Wrapper and binder are reconstituted tobacco products used by manufacturers of cigars.
|
|||
|
●
|
“
Restructuring and impairment expense
” represents expenses incurred in connection with activities intended to significantly change the size or nature of the business operations, including significantly reduced utilization of operating equipment, exit of a product or market or a significant workforce reduction and charges to reduce property, plant and equipment to its fair value.
|
|||
|
●
|
“
Start-up costs
” are costs incurred prior to generation of income producing activities in the case of a new plant, or costs incurred in excess of expected ongoing normal costs in the case of a new or rebuilt machine. Start-up costs can include excess variable costs such as raw materials, utilities and labor and unabsorbed fixed costs.
|
|||
|
●
|
“
Tipping paper
” joins the filter element to the tobacco-filled column of the cigarette and is both printable and glueable at high speeds.
|
|||
|
●
|
“
Wrapper
” covers the outside of cigars providing a uniform, finished appearance.
|
|||
|
Exhibit
|
|||
|
Number
|
Description
|
||
|
—
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
—
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
—
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
||
|
101.INS
|
—
|
XBRL Report Instance Document.**
|
|
|
101.SCH
|
—
|
XBRL Taxonomy Extension Schema Document. **
|
|
|
101.PRE
|
—
|
XBRL Taxonomy Presentation Linkbase Document. **
|
|
|
101.CAL
|
—
|
XBRL Calculation Linkbase Document. **
|
|
|
101.LAB
|
—
|
XBRL Taxonomy Label Linkbase Document**
|
|
| 101. DEF |
—
|
XBRL Taxonomy Extension Definition Linkbase Document** | |
| 101. REF |
—
|
XBRL Taxonomy Extension Reference Linkbase Document** | |
|
*
|
These Section 906 certifications are not being incorporated by reference into the Form 10-Q filing or otherwise deemed to be filed with the Securities and Exchange Commission.
|
|
**
|
In accordance with Regulation S-T, the XBRL-related information in Exhibit No. (101) to this Quarterly Report on Form 10-Q shall be deemed “furnished” and not “filed.”
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| PerkinElmer, Inc. | PKI |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|